Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 12, No 4 (2019) Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation Abstract  similar documents
A. V. Nikitina, F. V. Gorkavenko, Y. S. Saybel, M. V. Avxentyeva, M. S. Sura, D. V. Fedyaev
"... The aim was to assess the possibility of optimizing the costs of drugs for cancer patients ..."
 
Vol 17, No 4 (2024) Dynamics of anticancer drug use in Russian hospitals: a five-year retrospective analysis Abstract  similar documents
J. A. Agafonova, V. V. Omelyanovskiy
"... issues, particularly the use of oral anticancer drugs (ACDs) in day hospitals. These facilities often ..."
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... Rationale. From 2014 to 2017, the portion of antineoplastic drugs dossiers submitted ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... Background: In 2014 we firstly analyzed the formalized system (points and expert opinions) of drug ..."
 
Vol 18, No 1 (2025) The sale of medicines used for diabetes mellitus treatment in retail segment of Russian pharmaceutical market Abstract  similar documents
I. K. Petrukhina, A. M. Lazarev, T. K. Ryazanova, P. A. Lebedev, E. P. Gladunova, G. T. Glembotskaya
"... for drugs used to treat DM (according to Anatomical Therapeutic Chemical (ATС) classification) through ..."
 
Vol 7, No 1 (2014) PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE Abstract  similar documents
S. A. Rachina, R. S. Kozlov, Yu. A. Belkova
"... the use of and the effects of drugs in the whole population or in large groups of people in order ..."
 
Vol 10, No 1 (2017) RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION Abstract  similar documents
M. V. Sura
"... and sources of finance pertaining to the restrictive lists of drugs, which play a substantial role in the drug ..."
 
Vol 12, No 2 (2019) Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available Abstract  similar documents
F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev
"... trends in the general picture of drug prices and consumption. In the present study, we analyze ..."
 
Vol 17, No 1 (2024) Analysis of the availability of bronchodilators and anti-inflammatory drugs for patients with chronic obstructive pulmonary disease Abstract  PDF (Eng)  similar documents
E. A. Orlova, V. I. Petrov, I. P. Dorfman, O. V. Shatalova, M. A. Orlov
"... Background. The study of drug availability for patients with chronic obstructive pulmonary disease ..."
 
Vol 7, No 1 (2014) EVALUATION OF SAFETY OF DRUG THERAPY IN CLINICAL PRACTICE Abstract  similar documents
M. N. Kostyleva, Yu. B. Belousov, A. N. Gratsianskaya, S. S. Postnikov
"... ), account and analysis of the adverse reactions of drugs in post-marketing period are described. The off ..."
 
Vol 5, No 1 (2012) DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET Abstract  similar documents
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova
"... released antihypertensive drugs that are caused by decrease in average costof one prescription. ..."
 
Vol 9, No 3 (2016) DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Abstract  similar documents
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov
"... cancer in various regions of the Russian Federation in the framework of state programs of drug provision ..."
 
Vol 12, No 4 (2019) Clinical and economic analysis of drug costs in a general hospital in 2014-2018 Abstract  similar documents
A. T. Burbello, A. S. Fedorenko, E. L. Latariya, M. V. Pokladova, K. A. Zagorodnikova
"... Objectives. To study the structure of drug purchases by a general hospital considering the names ..."
 
Vol 15, No 3 (2022) Drug therapy for obesity in the Russian Federation: pharmacoepidemiological study Abstract  similar documents
V. V. Strizheletsky, Yu. М. Gomon, Е. А. Spichakova, А. S. Kolbin, А. А. Kalyapin, S. А. Makarov, А. B. Lomiya, F. М. Sultanova
"... Federation as drugs recommended by the Russian clinical guidelines for the pharmacotherapy of obesity ..."
 
Vol 15, No 1 (2022) The analysis of the consumption level of antihypertensive drugs and statins in a retail pharmacy of the Samara Region in 2015–2020 Abstract  similar documents
I. K. Petrukhina, P. A. Lebedev, E. P. Gladunova, T. K. Ryazanova, A. A. Garanin, P. R. Blinkova
"... Objective: to determine the compliance of antihypertensive drugs consumption with the trends ..."
 
Vol 16, No 2 (2023) Providing pharmaceutical consultation to visitors of pharmacy organizations in routine pharmaceutical practice Abstract  similar documents
M. S. Soboleva
"... complaints, diagnoses, special health conditions, the use of other drugs. For drug care, with the condition ..."
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... study goal is to prepare a road map for development of price regulation system and system of drug ..."
 
Vol 9, No 2 (2016) MANAGEMENT ASPECT OF THE PROBLEM OF NARCOTIC DRUGS USE Abstract  similar documents
S. Yu. Soboleva, A. V. Sobolev, I. A. Kaminskaya
"... The use of narcotic drugs in healthcare system nowadays is characterized by lawful aspects ..."
 
Vol 15, No 3 (2022) Economic aspects of using new chemotherapy regimens for multidrug and extensively drugresistant tuberculosis Abstract  similar documents
А. V. Kukurika
"... drug-resistant tuberculosis (MDR/XDR-TB) chemotherapy regimens. Material and methods. An analysis ..."
 
Vol 16, No 1 (2023) Compounding pharmacy regulations: experience of the North American pharmaceutical market Abstract  similar documents
D. D. Mamedov, D. S. Yurochkin, A. A. Leshkevich, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
"... requirements for ensuring quality and safety of compounding drugs, as well as historical and technical analysis ..."
 
Online First Osteoarthritis therapy misconcepts Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... , as new molecules appear, data concerning drugs/molecules that are already in use, appear as well ..."
 
Vol 14, No 2 (2021) Pharmacoepidemiology and pharmacoeconomics of multidrug- and extensively drug-resistant tuberculosis Abstract  similar documents
N. Yu. Nikolenko, D. А. Kudlay, N. P. Doktorova
"... Treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB ..."
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract  similar documents
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
"... development of approaches for complex drug assessment in Russia, also criteria for its evaluation were under ..."
 
Vol 16, No 2 (2023) From misconceptions to reasonable osteoarthritis patients therapy Abstract  similar documents
O. A. Shavlovskaya, О. А. Gromova, I. Yu. Torshin, I. D. Romanov
"... revised, as new molecules appear, data on drugs/molecules already in use, including data on adverse events ..."
 
Vol 17, No 3 (2024) Assessment of the impact of procurement centralization on the drug provision for patients within the High-Cost Nosology Program in the Russian Federation Abstract  similar documents
V. V. Omelyanovskiy, V. A. Ryagina, A. G. Kharitonova, K. I. Matrenin, A. A. Kingshott, O. V. Ashikhmina, M. V. Zhirov
"... Background. In the Russian Federation, patients receive expensive drugs from the federal budget ..."
 
Vol 17, No 3 (2024) Differential chemoproteomic analysis of RRS-1 candidate molecule and molecules of several nonsteroidal anti-inflammatory drugs Abstract  similar documents
P. A. Galenko-Yaroshevsky, I. Yu. Torshin, A. N. Gromov, O. A. Gromova, K. F. Suzdalev, R. A. Murashko, A. V. Zelenskaya, A. V. Zadorozhniy, T. R. Glechyan, G. V. Simavonyan, E.M. I. Muhammad
"... to evaluate the mechanisms and spectrum of action of nonsteroidal anti-inflammatory drugs (NSAIDs), including ..."
 
Vol 17, No 4 (2024) Scenario modeling of the drug prescription process for children: application of machine learning methods Abstract  similar documents
А. А. Kondrashov, М. М. Kurashov, Е. Е. Loskutova
"... Objective: determining the most appropriate machine learning method to solve the problem of drug ..."
 
Vol 17, No 4 (2024) Pharmacoeconomic study of active psoriatic arthritis treatment Abstract  similar documents
A. V. Rudakova, Т. V. Korotaeva
"... biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available ..."
 
Vol 18, No 1 (2025) Analysis of methotrexate use practice in patients with rheumatoid and psoriatic arthritis Abstract  similar documents
S. A. Doktorova, Yu. Yu. Grabovetskaya, A. V. Zuev, J. N. Aksenova-Sorokhtei, V. V. Rafalskiy
"... antirheumatic drugs. The current therapeutic concept for these conditions focuses on achieving and maintaining ..."
 
Vol 7, No 2 (2014) ANALYSIS OF DRUG PRODUCTS ASSORTMENT ACQUIRABLE BY HEALTHCARE ORGANIZATIONS FOR MEDICAL TREATMENT IN HOSPITAL SETTINGS WAS CONDUCTED Abstract  similar documents
M. G. Malaev
"... analysis of drug products assortment acquirable by healthcare organizations for medical treatment ..."
 
Vol 7, No 3 (2014) ASSESSMENT OF NECESSARY FINANCIAL EXPENSES ON THE DRUG SUPPLY OF THE PATIENTS WITH ORPHAN DISEASES IN THE RUSSIAN FEDERATION Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... the article presents the results of cost calculation on the drug supply of the patients ..."
 
Vol 7, No 4 (2014) АNALYSIS OF PSYCHOTROPIC DRUG CONSUPTION FOR SCHIZOPHRENIA TREATMENT IN DIFFERENT TYPE HOSPITALS Abstract  similar documents
P. S. Nosova, O. V. Reshetko
"... the goal of our research was to carry out an analysis of psychotropic drug utilization used ..."
 
Vol 7, No 4 (2014) APPLICATION OF MULTIPLE-CRITERIA ANALYSIS FOR OPTIMIZATION OF FINANCING OF RARE DISEASES Abstract  similar documents
V. V. Omelyanovskiy, V. K. Fedyaeva, O. Yu. Rebrova
"... financing of rare disease drugs remains a serious problem for both foreign countries and our ..."
 
Vol 8, No 2 (2015) REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS Abstract  similar documents
Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev
"... Orphan drugs are used for treatment of rare life-threatening diseases. There is no universal ..."
 
Vol 9, No 2 (2016) PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA Abstract  similar documents
N. A. Avxentyev, M. Yu. Frolov
"... The aim of the current study is pharmacoeconomic evaluation of using combined drug Vesomni ..."
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract  similar documents
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
"... Targeted drugs are recommended for treatment of metastatic colorectal cancer. Second and further ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... of the Russian Federation in three scenarios: Lacosamide as concomitant drug to standard therapy in comparison ..."
 
Vol 11, No 1 (2018) Modeling microbial drug-resistance: from mathematics to pharmacoeconomics Abstract  similar documents
Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
"... optimal algorithm for using antimicrobial agents (AMA) that would minimize the evolving drug-resistance ..."
 
Vol 11, No 4 (2018) Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions Abstract  similar documents
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
"... . Among the malignant LPDs, the highest costs of drug therapy in 2016 pertained to lymphosarcoma ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
 
Vol 12, No 3 (2019) Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support Abstract  similar documents
E. V. Eliseeva , E. S. Maneeva , R. K. Goncharova , A. V. Kropotov
"... the qualitative and quantitative indicators of drug supply. Materials and methods. We used the official ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... by the federal budget. The drug evaluation process includes five stages: a review of general information about ..."
 
Vol 15, No 3 (2022) Prospects for the use of chondroitin sulfate and glucosamine sulfate in the treatment of patients with obesity-associated osteoarthritis (metabolic syndrome) Abstract  similar documents
I. Yu. Torshin, О. A. Gromova, A. M. Lila
 
Vol 14, No 2 (2021) Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
"... Background. The introduction of innovative drugs has significantly increased the treatment ..."
 
Vol 14, No 2 (2021) Analysis of the availability and affordability of pharmaceuticals for children in need of palliative care Abstract  similar documents
D. M. Medvedeva, I. A. Narkevich, O. D. Nemyatykh
"... high scores of over-the-counter drugs (LDI>60%). Conclusions. The results call for better ..."
 
Vol 14, No 3 (2021) Peculiarities of administration of medications to patients with circulatory system diseases within the framework of the federal program of preferential provision of medicines Abstract  similar documents
I. K. Petrukhina, R. I. Yagudina, N. V. Veyner, T. K. Ryazanova, E. P. Gladunova, V. A. Kurkin, P. R. Blinkova, E. N. Zaitseva
 
Vol 16, No 2 (2023) Development of methodological approaches to the formation of a risk-based model to minimize the prevalence of adverse reactions in drug application in medical organizations of Moscow Abstract  similar documents
E. V. Kuznetsova, M. V. Zhuravleva, I. A. Mikhailov, T. I. Kurnosova
"... using drugs based on a comprehensive assessment of risk factors. Material and methods. We used ..."
 
Vol 16, No 4 (2023) Sales of antitumor drugs in the retail segment of the Russian pharmaceutical market Abstract  similar documents
I. K. Petrukhina, T. K. Ryazanova, E. P. Gladunova, A. M. Lazarev, A. A. Krivova
"... Objective: to study the features of the population consumption of antitumor drugs (ATDs) of groups ..."
 
Vol 16, No 4 (2023) Investigating the current state of the Russian market for drugs treating infectious and inflammatory conditions of oral cavity and oropharynx to demonstrate the need for new drug development Abstract  PDF (Eng)  similar documents
V. I. Zvereva, D. R. Dzhavakhyan, V. N. Dul, V. S. Bobyleva, A. A. Markaryan, E. I. Morkovin, D. V. Kurkin, M. A. Dzhavakhyan
"... Objective: to assess the relevance and commercial prospects of bringing to market a drug ..."
 
Vol 17, No 1 (2024) Compounding pharmacy regulations: experience of the Latvian pharmaceutical market Abstract  similar documents
D. D. Mamedov, D. S. Yurochkin, D. D. Zelikova, S. E. Erdni-Garyaev, Z. M. Golant, I. A. Narkevich
"... The article aims to examine technological, organizational and regulatory aspects of drug quality ..."
 
1 - 50 of 93 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)